BL(SZ:002592) Shang Hai Zheng Quan Bao·2025-09-01 20:05Core Viewpoint - Nanning Baling Technology Co., Ltd. is facing ongoing risks due to unauthorized guarantees made by its former subsidiary, leading to significant financial implications and the implementation of risk warnings on its stock [2][3]. Group 1: Overview of Violations - The company’s former subsidiary, Hainan Hongrun Tianyuan Gene Biotechnology Co., Ltd., made unauthorized guarantees totaling 4.66 billion yuan through three time deposits without proper company approval, resulting in the stock being marked as ST since July 2, 2020 [2]. Group 2: Legal Actions and Progress - Hainan Hongrun has initiated lawsuits against Guangzhou Bank and GF Bank regarding the unauthorized guarantees. The first case against Guangzhou Bank involved a 1.46 billion yuan deposit, where the initial ruling was overturned in favor of Hainan Hongrun, ordering the bank to return 73 million yuan plus interest. However, both parties have appealed to the Supreme Court, which upheld the higher court's decision [3][4]. - In the case against GF Bank concerning a 1.7 billion yuan pledge, the initial ruling was also overturned, with the court ordering GF Bank to return 85 million yuan plus interest. This case is still pending as Hainan Hongrun has not yet received any funds [3][4]. - A separate case involving a 1.5 billion yuan deposit was dismissed by the court due to potential criminal implications, and Hainan Hongrun has appealed this decision [4]. Group 3: Current Status and Future Outlook - As of the announcement date, Hainan Hongrun has not recovered any funds from these legal proceedings, and the uncertainty surrounding the recovery of funds continues to pose risks for the company [5]. - The company will keep monitoring the situation and fulfill its disclosure obligations as required by law [5].